Published in J Hepatol on May 01, 1999
Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol (2001) 1.31
Detection of T lymphocyte subsets and mIL-2R on surface of PBMC in patients with hepatitis B. World J Gastroenterol (2003) 0.95
Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice. Immunology (2001) 0.95
Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses. Clin Exp Immunol (2005) 0.93
Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy. Clin Exp Immunol (2004) 0.92
Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection. World J Gastroenterol (2006) 0.92
Randomized controlled study investigating viral suppression and serological response following pre-S1/pre-S2/S vaccine therapy combined with lamivudine treatment in HBeAg-positive patients with chronic hepatitis B. Antimicrob Agents Chemother (2009) 0.86
Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease. J Gastroenterol (2010) 0.86
Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro. Clin Exp Immunol (2007) 0.86
Impaired dendritic cell functions because of depletion of natural killer cells disrupt antigen-specific immune responses in mice: restoration of adaptive immunity in natural killer-depleted mice by antigen-pulsed dendritic cell. Clin Exp Immunol (2008) 0.84
Hepatitis B virus infection: An insight into infection outcomes and recent treatment options. Virusdisease (2015) 0.80
Interleukin-12 production in chronic hepatitis C infection. J Hepatol (2000) 0.77
The inverse association between the presence of antibody to hepatitis B surface antigen and atopy in young adults. Korean J Intern Med (2005) 0.75
Resetting central and peripheral circadian oscillators in transgenic rats. Science (2000) 8.63
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 6.96
Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma (1984) 3.74
Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature (2001) 3.24
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology (2001) 2.62
Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol (1989) 2.61
Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney Int (2006) 2.57
Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med (1991) 2.31
A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood (1994) 2.27
Specific phases of root hair attachment in the Rhizobium trifolii-clover symbiosis. Appl Environ Microbiol (1984) 2.10
Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci U S A (1988) 2.08
Fluorescent leprosy antibody absorption (FLA-ABS) test for detecting subclinical infection with Mycobacterium leprae. Int J Lepr Other Mycobact Dis (1980) 1.97
Replication of the escherichia coli K12 chromosome. Proc Natl Acad Sci U S A (1967) 1.88
The rubble-pile asteroid Itokawa as observed by Hayabusa. Science (2006) 1.87
Establishment of a simple and practical procedure applicable to therapeutic angiogenesis. Circulation (1999) 1.83
Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein. Oncogene (2008) 1.74
Genetic analysis of the DNA-dependent protein kinase reveals an inhibitory role of Ku in late S-G2 phase DNA double-strand break repair. J Biol Chem (2001) 1.73
Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells. J Cell Biol (1993) 1.71
Relation between diet and protozoal population in the rumen. Br J Nutr (1973) 1.69
Stimulation of clover root hair infection by lectin-binding oligosaccharides from the capsular and extracellular polysaccharides of Rhizobium trifolii. J Bacteriol (1984) 1.69
Chromosome replication in Escherichia coli K12 mutant affected in the process of DNA initiation. Genetics (1971) 1.64
Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood (1995) 1.62
Techniques, indications and results of intraoperative radiotherapy of advanced cancers. Radiology (1975) 1.62
Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. Proc Natl Acad Sci U S A (1997) 1.61
Effect of mizoribine on glomerulonephritis of early-stage IgA nephropathy in ddY mice. Nephron (1998) 1.60
Bacteriophage-induced acidic heteropolysaccharide lyases that convert the acidic heteropolysaccharides of Rhizobium trifolii into oligosaccharide units. J Bacteriol (1984) 1.60
Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci U S A (1997) 1.59
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol (2009) 1.58
CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity (2000) 1.57
Thallium-201 SPECT of adjacent intracranial tumours: a contrast in thallium kinetics. Neuroradiology (1999) 1.55
Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. J Cell Biol (1992) 1.51
Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients. J Clin Invest (1985) 1.49
Interferon therapy for patients more than 60 years of age with chronic hepatitis C. J Gastroenterol Hepatol (1995) 1.48
Induction of Th2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens. J Immunol (1999) 1.47
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study. Br J Dermatol (2013) 1.46
Usefulness of transcutaneous Doppler jugular venous echo to predict pulmonary hypertension in COPD patients. Eur Respir J (2001) 1.46
The dorsiflexion-eversion test for diagnosis of tarsal tunnel syndrome. J Bone Joint Surg Am (2001) 1.46
Intraoperative radiotherapy: the Japanese experience. Int J Radiat Oncol Biol Phys (1981) 1.45
Touchdown of the Hayabusa spacecraft at the Muses Sea on Itokawa. Science (2006) 1.43
Immunosuppressive and antiparasitic effects of cyclosporin A on Hymenolepis nana infection in mice. Int J Parasitol (1998) 1.41
Coexistence of morphea and systemic sclerosis. Dermatology (1993) 1.40
Hepatocyte response to continuous low dose-rate radiation in radioimmunotherapy assessed by micronucleus assay. Int J Radiat Biol (1992) 1.39
Studies on the antigenic specificity of Mycobacterium leprae. I. Demonstration of soluble antigens in leprosy nodules by immunodiffusion. Int J Lepr Other Mycobact Dis (1970) 1.39
Near-death asthmatic reaction induced by disodium cromoglycate. Intern Med (1996) 1.38
Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene (2000) 1.38
Identification of a receptor for reg (regenerating gene) protein, a pancreatic beta-cell regeneration factor. J Biol Chem (2000) 1.36
At least five DH genes of human immunoglobulin heavy chains are encoded in 9-kilobase DNA fragments. Eur J Immunol (1988) 1.35
Incipient space weathering observed on the surface of Itokawa dust particles. Science (2011) 1.35
Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics (2000) 1.33
A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Pharmacogenomics J (2011) 1.32
Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem Biophys Res Commun (2001) 1.32
Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol (1996) 1.32
Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes. Biochem Biophys Res Commun (1998) 1.31
Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver. J Biol Chem (2001) 1.31
Hepatic abscess secondary to a fishbone penetrating the gastric wall: CT demonstration. Comput Med Imaging Graph (1991) 1.31
Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood (1994) 1.29
Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Biochem Biophys Res Commun (1999) 1.29
Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J Exp Med (2001) 1.29
Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest (2001) 1.28
Activation of Reg gene, a gene for insulin-producing beta -cell regeneration: poly(ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly(ADP-ribosyl)ation. Proc Natl Acad Sci U S A (2001) 1.28
ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J Cell Physiol (1999) 1.28
Computed tomographic scan of the chest, latex agglutination test and plasma (1AE3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients. Haematologica (2000) 1.27
Comparison of 22 species of Mycobacteria by immunodiffusion against an absorbed reference leprosy serum. Int J Lepr Other Mycobact Dis (1981) 1.26
Intraoperative radiotherapy of gastric cancer. Cancer (1974) 1.26
Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin Exp Immunol (2011) 1.26
Activation of latent transforming growth factor beta. Adv Pharmacol (1993) 1.26
Sectional collapsed denture for a partially edentulous patient with microstomia: a clinical report. J Prosthet Dent (2000) 1.26
Light- and guanosine 5'-3-O-(thio)triphosphate-sensitive localization of a G protein and its effector on detergent-resistant membrane rafts in rod photoreceptor outer segments. J Biol Chem (2001) 1.25
KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol (1997) 1.25
Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury. J Cell Physiol (1998) 1.22
Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology (1996) 1.21
Sequestration of holotrich protozoa in the reticulo-rumen of cattle. Appl Environ Microbiol (1981) 1.20
Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor. Biochem Biophys Res Commun (1999) 1.19
Promotion of infection thread formation by substances from Rhizobium. Appl Environ Microbiol (1980) 1.19
Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis (1993) 1.17
Clinical experiences with intraoperative radiotherapy of locally advanced cancers. Cancer (1980) 1.17
Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int Immunol (1999) 1.17
Absence of DNA in peroxisomes of Candida tropicalis. J Bacteriol (1982) 1.17
Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma. J Hepatol (1999) 1.16
Cytokinesis regulator ECT2 changes its conformation through phosphorylation at Thr-341 in G2/M phase. Oncogene (2006) 1.16
In vitro simulation of rumen fermentation: apparatus and effects of dilution rate and continuous dialysis on fermentation and protozoal population. J Anim Sci (1973) 1.16
Down-regulation of translation driven by hepatitis C virus internal ribosomal entry site by the 3' untranslated region of RNA. Arch Virol (2001) 1.15
Angiogenesis inhibition by transdominant mutant Ets-1. J Cell Physiol (2000) 1.15
Circulating KL-6 levels in patients with drug induced pneumonitis. Thorax (2003) 1.15
Chemosensitization by buthionine sulfoximine in vivo. Int J Radiat Oncol Biol Phys (1986) 1.15
Mapping of a gene for the increased susceptibility of B1 cells to Mott cell formation in murine autoimmune disease. J Immunol (1997) 1.15
Noninvasive diagnosis of the degree of hepatic fibrosis using ultrasonography in patients with chronic liver disease due to hepatitis C virus. Eur J Clin Invest (2001) 1.15
CT simulator: a new 3-D planning and simulating system for radiotherapy: Part 1. Description of system. Int J Radiat Oncol Biol Phys (1990) 1.14
Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia. Proc Natl Acad Sci U S A (1998) 1.14
Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res (1992) 1.14
Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24. Blood (1997) 1.13